Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,995.21 +559.63 (+0.84%) CMC Crypto 200
1,372.63 -1.21 (-0.09%)
XNCR Aug 2024 25.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 01:13PM EDT
| Previous close | 3.6000 |
| Open | 3.4000 |
| Bid | 0.6000 |
| Ask | 5.0000 |
| Strike | 25.00 |
| Expiry date | 2024-08-16 |
| Day's range | 3.4000 - 3.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
Simply Wall St.Xencor First Quarter 2024 Earnings: Misses Expectations
Xencor ( NASDAQ:XNCR ) First Quarter 2024 Results Key Financial Results Revenue: US$12.8m (down 33% from 1Q 2023). Net...
- GuruFocus.com
Xencor Inc (XNCR) Q1 2024 Earnings: Misses Revenue and Earnings Estimates
Comprehensive Analysis of Financial Performance and Strategic Initiatives
Business WireXencor Reports First Quarter 2024 Financial Results
PASADENA, Calif., May 09, 2024--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today reported financial results for the first quarter ended March 31, 2024 and provided a review of recent clinical and business highlights.
© 2024 Yahoo. All rights reserved.